Home/Clinical Trials
RecruitingPhase 3CT-2023-116
Once-weekly lorvatide in adults with obesity
Obesity · Cardiometabolic
Ages 18 years and older730 participantsBoston, MA, San Diego, CA +3 more
RecruitingPhase 2CT-2025-118
CLV-419 in heart failure with preserved ejection fraction
Heart failure · Cardiometabolic
Ages 18 to 75 years270 participantsToronto, Canada, Tokyo, Japan +2 more
Active, not recruitingPhase 3CT-2026-117
Semavotide in obesity with type 2 diabetes
Obesity · Cardiometabolic
Ages 18 to 80 years1,130 participantsMadrid, Spain, Raleigh, NC +1 more
Active, not recruitingPhase 3CT-2023-120
Calvasiran cardiovascular outcomes study
Hyperlipidemia · Cardiometabolic
Ages 18 years and older2,940 participantsSan Diego, CA, Madrid, Spain
CompletedPhase 1CT-2024-119
CLV-427 in adults with elevated Lp(a)
Cardiovascular disease · Cardiometabolic
Ages 18 to 80 years50 participantsChicago, IL, Raleigh, NC
CompletedPhase 1CT-2023-128
CLV-419 biomarker study
Heart failure · Cardiometabolic
Ages 18 years and older90 participantsSeoul, South Korea, Toronto, Canada +3 more
Study listings are fictional. Talk with your doctor before joining any clinical trial.